Modified Red Blood Cells for COVID-19 Vaccination
Researchers at McMaster University in Ontario, Canada created engineered red blood cells to act as a new COVID-19 vaccine technology. The cell membranes have been studded with the SARS-CoV-2 spike protein, and in experiments the researchers have cond...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Cardiology Materials Medicine Nanomedicine Source Type: blogs
More News: Canada Health | Cardiology | Covid Vaccine | COVID-19 | Genetics | Heart | Medical Devices | Nanotechnology | Pandemics | SARS | Study | Vaccines